Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Freund

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Iscience|January 23, 2023
Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigensRon Yefet, Nadav Friedel, Hadas Tamir, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancerM A Sutton, C T Freund, S A Berkman, et al.
Elife|May 27, 2017
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodiesHaoqing Wang, Harry B Gristick, Louise Scharf, et al.
Implementation Science : IS|September 15, 2016
Process evaluation of five tailored programs to improve the implementation of evidence-based recommendations for chronic conditions in primary careC Jäger, J Steinhäuser, T Freund, et al.
Nature Communications|May 14, 2025
Molecular mechanism of thyroxine transport by monocarboxylate transportersMatteo Tassinari, Giorgia Tanzi, Francesco Maggiore, et al.
Nature Communications|March 30, 2018
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelopeChristopher O Barnes, Harry B Gristick, Natalia T Freund, et al.
Biorxiv : the Preprint Server for Biology|August 1, 2025
Early Antibody-Mediated Immunity to Tuberculosis in Mice Requires NLRP3Rania Bouzeyen, Nyaradzai Sithole, Avia Watson, et al.
Anticancer Research|June 6, 1998
The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoterX Tong, D G Engehausen, C T Freund, et al.
Hybridoma|April 22, 1999
Comparison of long-term survival of cytomegalovirus promotre versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancerX Tong, D G Engehausen, C T Freund, et al.
Infection and Immunity|January 21, 2026
Antibodies in tuberculosis: functional capacity as key determinantKrista E van Meijgaarden, Patricia S Grace, Natalia T Freund, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Iscience|January 23, 2023
Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigensRon Yefet, Nadav Friedel, Hadas Tamir, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancerM A Sutton, C T Freund, S A Berkman, et al.
Elife|May 27, 2017
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodiesHaoqing Wang, Harry B Gristick, Louise Scharf, et al.
Implementation Science : IS|September 15, 2016
Process evaluation of five tailored programs to improve the implementation of evidence-based recommendations for chronic conditions in primary careC Jäger, J Steinhäuser, T Freund, et al.
Nature Communications|May 14, 2025
Molecular mechanism of thyroxine transport by monocarboxylate transportersMatteo Tassinari, Giorgia Tanzi, Francesco Maggiore, et al.
Nature Communications|March 30, 2018
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelopeChristopher O Barnes, Harry B Gristick, Natalia T Freund, et al.
Biorxiv : the Preprint Server for Biology|August 1, 2025
Early Antibody-Mediated Immunity to Tuberculosis in Mice Requires NLRP3Rania Bouzeyen, Nyaradzai Sithole, Avia Watson, et al.
Anticancer Research|June 6, 1998
The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoterX Tong, D G Engehausen, C T Freund, et al.
Hybridoma|April 22, 1999
Comparison of long-term survival of cytomegalovirus promotre versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancerX Tong, D G Engehausen, C T Freund, et al.
Infection and Immunity|January 21, 2026
Antibodies in tuberculosis: functional capacity as key determinantKrista E van Meijgaarden, Patricia S Grace, Natalia T Freund, et al.
Pageof 8